EirGenix (Taiwan) Performance
| 6589 Stock | TWD 89.00 0.80 0.91% |
EirGenix has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.11, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning EirGenix are expected to decrease at a much lower rate. During the bear market, EirGenix is likely to outperform the market. EirGenix right now shows a risk of 1.75%. Please confirm EirGenix total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if EirGenix will be following its price patterns.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in EirGenix are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, EirGenix may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 908.3 M | |
| Total Cashflows From Investing Activities | -1.8 B | |
| Free Cash Flow | -199.6 M |
EirGenix |
EirGenix Relative Risk vs. Return Landscape
If you would invest 8,410 in EirGenix on August 29, 2024 and sell it today you would earn a total of 490.00 from holding EirGenix or generate 5.83% return on investment over 90 days. EirGenix is generating 0.1049% of daily returns and assumes 1.7489% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than EirGenix, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
EirGenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EirGenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EirGenix, and traders can use it to determine the average amount a EirGenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.06
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 6589 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.75 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average EirGenix is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EirGenix by adding it to a well-diversified portfolio.
EirGenix Fundamentals Growth
EirGenix Stock prices reflect investors' perceptions of the future prospects and financial health of EirGenix, and EirGenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EirGenix Stock performance.
| Return On Equity | -5.0E-4 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | (0) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 39.51 B | |||
| Shares Outstanding | 304.26 M | |||
| Price To Book | 4.38 X | |||
| Price To Sales | 25.64 X | |||
| Revenue | 1.7 B | |||
| EBITDA | 164.98 M | |||
| Cash And Equivalents | 626.11 M | |||
| Cash Per Share | 3.70 X | |||
| Debt To Equity | 52.70 % | |||
| Book Value Per Share | 35.17 X | |||
| Cash Flow From Operations | (29.9 M) | |||
| Earnings Per Share | 1.96 X | |||
| Total Asset | 11.44 B | |||
About EirGenix Performance
Evaluating EirGenix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if EirGenix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EirGenix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
EirGenix Inc. operates as a contract development and manufacturing company worldwide. Its services include cell line development, process development, analytical sciences and quality control, cGMP manufacturing, and antibody drug conjugate. EIRGENIX INC operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 179 people.Things to note about EirGenix performance evaluation
Checking the ongoing alerts about EirGenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EirGenix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 1.7 B. Net Loss for the year was (42.58 M) with profit before overhead, payroll, taxes, and interest of 1.09 B. | |
| EirGenix has accumulated about 626.11 M in cash with (29.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7. | |
| Roughly 33.0% of the company shares are owned by insiders or employees |
- Analyzing EirGenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EirGenix's stock is overvalued or undervalued compared to its peers.
- Examining EirGenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EirGenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EirGenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EirGenix's stock. These opinions can provide insight into EirGenix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for EirGenix Stock Analysis
When running EirGenix's price analysis, check to measure EirGenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EirGenix is operating at the current time. Most of EirGenix's value examination focuses on studying past and present price action to predict the probability of EirGenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EirGenix's price. Additionally, you may evaluate how the addition of EirGenix to your portfolios can decrease your overall portfolio volatility.